Deutsche Bank Ag\ Dyne Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

$245 Billion
Q1 2025

A detailed history of Deutsche Bank Ag\ transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 317,664 shares of DYN stock, worth $3.21 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

317,664

Previous 70,961 347.66%

Holding current value

$3.21 Million

Previous $1.67 Million 98.8%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	BUY	$10.46 - $25.46 $2.58 Million - $6.28 Million	246,703 Added 347.66%	317,664 $3.32 Million
Q4 2024 Feb 14, 2025	BUY	$23.56 - $35.55 $567,890 - $856,897	24,104 Added 51.44%	70,961 $1.67 Million
Q3 2024 Jun 26, 2025	SELL	$31.94 - $47.04 $8.65 Million - $12.7 Million	-270,807 Reduced 85.25%	46,857 $1.68 Million
Q3 2024 Nov 13, 2024	BUY	$31.94 - $47.04 $409,374 - $602,911	12,817 Added 37.65%	46,857 $1.68 Million
Q2 2024 Jun 12, 2025	SELL	$23.65 - $35.63 $6.71 Million - $10.1 Million	-283,624 Reduced 89.28%	34,040 $1.2 Million
Q2 2024 Aug 14, 2024	BUY	$23.65 - $35.63 $164,651 - $248,056	6,962 Added 25.71%	34,040 $1.2 Million
Q1 2024 Jun 02, 2025	SELL	$13.06 - $29.18 $3.8 Million - $8.48 Million	-290,586 Reduced 91.48%	27,078 $768,000
Q1 2024 May 15, 2024	BUY	$13.06 - $29.18 $80,671 - $180,244	6,177 Added 29.55%	27,078 $768,000
Q4 2023 Feb 14, 2024	SELL	$6.62 - $13.64 $3,455 - $7,120	-522 Reduced 2.44%	20,901 $277,000
Q3 2023 Nov 09, 2023	BUY	$8.6 - $12.18 $34,666 - $49,097	4,031 Added 23.18%	21,423 $191,000
Q2 2023 Aug 14, 2023	SELL	$8.53 - $14.28 $18,126 - $30,345	-2,125 Reduced 10.89%	17,392 $195,000
Q1 2023 May 15, 2023	BUY	$10.88 - $15.0 $12,152 - $16,755	1,117 Added 6.07%	19,517 $224,000
Q4 2022 Feb 13, 2023	BUY	$9.37 - $13.8 $39,438 - $58,084	4,209 Added 29.66%	18,400 $213,000
Q3 2022 Nov 14, 2022	SELL	$7.2 - $15.17 $417 - $879	-58 Reduced 0.41%	14,191 $180,000
Q2 2022 Aug 11, 2022	SELL	$4.36 - $10.5 $8,981 - $21,630	-2,060 Reduced 12.63%	14,249 $98,000
Q1 2022 May 13, 2022	SELL	$6.52 - $12.27 $12,635 - $23,779	-1,938 Reduced 10.62%	16,309 $157,000
Q4 2021 Feb 11, 2022	BUY	$11.89 - $16.07 $11,580 - $15,652	974 Added 5.64%	18,247 $217,000
Q3 2021 Nov 04, 2021	SELL	$15.6 - $21.46 $8,689 - $11,953	-557 Reduced 3.12%	17,273 $281,000
Q2 2021 Aug 11, 2021	BUY	$15.94 - $22.33 $131,154 - $183,731	8,228 Added 85.69%	17,830 $375,000
Q1 2021 May 13, 2021	SELL	$14.0 - $29.3 $31,948 - $66,862	-2,282 Reduced 19.2%	9,602 $149,000
Q4 2020 Feb 16, 2021	BUY	$16.81 - $23.94 $199,770 - $284,502	11,884 New	11,884 $250,000

Others Institutions Holding DYN

# of Institutions

216

Shares Held

116M

Call Options Held

322K

Put Options Held

66.2K

View Full List

About Dyne Therapeutics, Inc.

Ticker DYN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,765,400
Market Cap $524M
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...

More about DYN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account